methimazole and Skin-Ulcer

methimazole has been researched along with Skin-Ulcer* in 3 studies

Other Studies

3 other study(ies) available for methimazole and Skin-Ulcer

ArticleYear
Aplasia cutis congenita after methimazole exposure in utero successfully treated with basic fibroblast growth factor.
    International journal of dermatology, 2010, Volume: 49, Issue:3

    Topics: Antithyroid Agents; Ectodermal Dysplasia; Female; Fibroblast Growth Factor 2; Humans; Infant, Newborn; Methimazole; Pregnancy; Prenatal Exposure Delayed Effects; Skin Ulcer

2010
Non-purulent furunculoid cutaneous nodules as an indicator for agranulocytosis.
    Acta dermato-venereologica, 1998, Volume: 78, Issue:6

    Topics: Agranulocytosis; Antithyroid Agents; Diagnosis, Differential; Escherichia coli Infections; Female; Follow-Up Studies; Furunculosis; Humans; Methimazole; Middle Aged; Skin Ulcer

1998
ANCA-associated vasculitis and lupus-like syndrome caused by methimazole.
    Clinical and experimental dermatology, 1995, Volume: 20, Issue:4

    A 24-year-old woman with Graves' disease treated with methimazole for 4 years, developed recalcitrant ulcers on the lower legs. Histological studies demonstrated vasculitis in deep dermal vessels accompanied by C3 deposition. Laboratory investigation revealed lupus-like abnormalities (leucocytopenia, positive antinuclear and antidouble strand (ds) DNA antibodies, and positive ANCA). The leg ulcers dramatically improved after methimazole was withdrawn. In addition, leucocytopenia and the immunological abnormalities soon faded. Although lupus-like syndrome is well known to be induced by antithyroid drugs, vasculitis is a rare complication. To the best of our knowledge, this is the first report describing ANCA-associated vasculitis caused by methimazole.

    Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Autoantibodies; Biomarkers; Female; Graves Disease; Humans; Lupus Vulgaris; Methimazole; Skin Ulcer; Vasculitis

1995